Leffell is an internationally recognized expert in skin cancer and the Mohs technique, plastic reconstruction, and new technologies in dermatology.
In January 2012, Dr. Leffell stepped down as chief executive officer of the Yale Medical Group [2], after 15 years of leadership of the organization.
Leffell was a member of the international team that discovered PTC1, a tumor suppressor gene that plays a critical role in the development of hereditary and sporadic basal cell cancer.
[10] In collaboration with Susan Mayne, PhD at the Yale School of Public Health, Leffell has researched the role of tanning parlors in the development of skin cancer in young women.
The book, originally published by Hyperion in 2000 has become a standard reference for the lay public on all aspects of skin health and disease and is now available as an ebook Totalskinandhealth.
Leading a team of operations and strategic executives he focused on developing a patient-centered approach in a large, complex specialty organization.
Stephen Rimar, MD, who helped develop the program published one of the first textbooks of its kind based on the multidisciplinary lectures intended to provide practicing clinicians with fundamental knowledge of business.
The centers, which represent huge capital investment, will always be the high cost providers of healthcare but will also be the source of cost-reducing innovation in medical care.